Literature DB >> 16880516

UV radiation induces delayed hyperrecombination associated with hypermutation in human cells.

Stephen T Durant1, Kimberly S Paffett, Meena Shrivastav, Graham S Timmins, William F Morgan, Jac A Nickoloff.   

Abstract

Ionizing radiation induces delayed genomic instability in human cells, including chromosomal abnormalities and hyperrecombination. Here, we investigate delayed genome instability of cells exposed to UV radiation. We examined homologous recombination-mediated reactivation of a green fluorescent protein (GFP) gene in p53-proficient human cells. We observed an approximately 5-fold enhancement of delayed hyperrecombination (DHR) among cells surviving a low dose of UV-C (5 J/m2), revealed as mixed GFP+/- colonies. UV-B did not induce DHR at an equitoxic (75 J/m2) dose or a higher dose (150 J/m2). UV is known to induce delayed hypermutation associated with increased oxidative stress. We found that hypoxanthine phosphoribosyltransferase (HPRT) mutation frequencies were approximately 5-fold higher in strains derived from GFP+/- (DHR) colonies than in strains in which recombination was directly induced by UV (GFP+ colonies). To determine whether hypermutation was directly caused by hyperrecombination, we analyzed hprt mutation spectra. Large-scale alterations reflecting large deletions and insertions were observed in 25% of GFP+ strains, and most mutants had a single change in HPRT. In striking contrast, all mutations arising in the hypermutable GFP+/- strains were small (1- to 2-base) changes, including substitutions, deletions, and insertions (reminiscent of mutagenesis from oxidative damage), and the majority were compound, with an average of four hprt mutations per mutant. The absence of large hprt deletions in DHR strains indicates that DHR does not cause hypermutation. We propose that UV-induced DHR and hypermutation result from a common source, namely, increased oxidative stress. These two forms of delayed genome instability may collaborate in skin cancer initiation and progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16880516      PMCID: PMC1592811          DOI: 10.1128/MCB.00444-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  67 in total

Review 1.  How nucleotide excision repair protects against cancer.

Authors:  E C Friedberg
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

2.  Specificity of mutations induced by methyl methanesulfonate in mismatch repair-deficient human cancer cell lines.

Authors:  W E Glaab; K R Tindall; T R Skopek
Journal:  Mutat Res       Date:  1999-06-30       Impact factor: 2.433

Review 3.  RecQ helicases: caretakers of the genome.

Authors:  Ian D Hickson
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

Review 4.  UVR-induced G-C to C-G transversions from oxidative DNA damage.

Authors:  Katsuhito Kino; Hiroshi Sugiyama
Journal:  Mutat Res       Date:  2005-01-25       Impact factor: 2.433

5.  Enhanced tumor formation in mice heterozygous for Blm mutation.

Authors:  Kathleen Heppner Goss; Mary A Risinger; Jennifer J Kordich; Maureen M Sanz; Joel E Straughen; Lisa E Slovek; Anthony J Capobianco; James German; Gregory P Boivin; Joanna Groden
Journal:  Science       Date:  2002-09-20       Impact factor: 47.728

6.  Oxidative stress-induced homologous recombination as a novel mechanism for phenytoin-initiated toxicity.

Authors:  Louise M Winn; Perry M Kim; Jac A Nickoloff
Journal:  J Pharmacol Exp Ther       Date:  2003-05-02       Impact factor: 4.030

7.  Ionizing radiation induces delayed hyperrecombination in Mammalian cells.

Authors:  Lei Huang; Suzanne Grim; Leslie E Smith; Perry M Kim; Jac A Nickoloff; Olga G Goloubeva; William F Morgan
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

8.  Multiplex polymerase chain reaction analysis of UV-A- and UV-B-induced delayed and early mutations in V79 Chinese hamster cells.

Authors:  Jostein Dahle; Paul Noordhuis; Trond Stokke; Debbie Hege Svendsrud; Egil Kvam
Journal:  Photochem Photobiol       Date:  2005 Jan-Feb       Impact factor: 3.421

9.  Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations.

Authors:  Malihe Eskandarpour; Jamileh Hashemi; Lena Kanter; Ulrik Ringborg; Anton Platz; Johan Hansson
Journal:  J Natl Cancer Inst       Date:  2003-06-04       Impact factor: 13.506

10.  UV-light induces delayed mutations in Chinese hamster cells.

Authors:  T D Stamato; E Richardson; M L Perez
Journal:  Mutat Res       Date:  1995-05       Impact factor: 2.433

View more
  8 in total

1.  Low- and High-LET Ionizing Radiation Induces Delayed Homologous Recombination that Persists for Two Weeks before Resolving.

Authors:  Christopher P Allen; Hirokazu Hirakawa; Nakako Izumi Nakajima; Sophia Moore; Jingyi Nie; Neelam Sharma; Mayumi Sugiura; Yuko Hoki; Ryoko Araki; Masumi Abe; Ryuichi Okayasu; Akira Fujimori; Jac A Nickoloff
Journal:  Radiat Res       Date:  2017-05-23       Impact factor: 2.841

2.  Amifostine metabolite WR-1065 disrupts homologous recombination in mammalian cells.

Authors:  Jaroslaw Dziegielewski; Wilfried Goetz; Jeffrey S Murley; David J Grdina; William F Morgan; Janet E Baulch
Journal:  Radiat Res       Date:  2010-02       Impact factor: 2.841

3.  Targeted gene knock in and sequence modulation mediated by a psoralen-linked triplex-forming oligonucleotide.

Authors:  Alokes Majumdar; Parameswary A Muniandy; Jia Liu; Ji-lan Liu; Su-ting Liu; Bernard Cuenoud; Michael M Seidman
Journal:  J Biol Chem       Date:  2008-02-25       Impact factor: 5.157

Review 4.  Paths from DNA damage and signaling to genome rearrangements via homologous recombination.

Authors:  Jac A Nickoloff
Journal:  Mutat Res       Date:  2017-07-24       Impact factor: 3.151

5.  Telomerase-independent paths to immortality in predictable cancer subtypes.

Authors:  Stephen T Durant
Journal:  J Cancer       Date:  2012-01-31       Impact factor: 4.207

6.  Green tea extract promotes DNA repair in a yeast model.

Authors:  Shin Yen Chong; Hsin-Yi Chiang; Tzu-Hung Chen; Yi-Ju Liang; Yi-Chen Lo
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

7.  The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.

Authors:  Stephen T Durant; Li Zheng; Yingchun Wang; Kan Chen; Lingli Zhang; Tianwei Zhang; Zhenfan Yang; Lucy Riches; Antonio G Trinidad; Jacqueline H L Fok; Tom Hunt; Kurt G Pike; Joanne Wilson; Aaron Smith; Nicola Colclough; Venkatesh Pilla Reddy; Andrew Sykes; Annika Janefeldt; Peter Johnström; Katarina Varnäs; Akihiro Takano; Stephanie Ling; Jonathan Orme; Jonathan Stott; Caroline Roberts; Ian Barrett; Gemma Jones; Martine Roudier; Andrew Pierce; Jasmine Allen; Jenna Kahn; Amrita Sule; Jeremy Karlin; Anna Cronin; Melissa Chapman; Kristoffer Valerie; Ruth Illingworth; Martin Pass
Journal:  Sci Adv       Date:  2018-06-20       Impact factor: 14.136

8.  ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data.

Authors:  Nalee Kim; Se Hoon Kim; Seok-Gu Kang; Ju Hyung Moon; Jaeho Cho; Chang-Ok Suh; Hong In Yoon; Jong Hee Chang
Journal:  Radiat Oncol       Date:  2020-07-31       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.